GAUSH MEDITECH(02407.HK)

Company Encyclopedia
View More
name
GAUSH MEDITECH
02407.HK
Gaush Meditech Ltd. engages in the research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company’s product portfolio comprising proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, treatment, or surgeries, being vitreoretinal diseases, cataracts, refractive surgery, glaucoma, ocular surface diseases, optometry, and pediatric ophthalmology. Gaush Meditech Ltd.
136.55 B
02407.HKMarket value -Rank by Market Cap -/-

Financial Score

01/01/2026 Update
B
Health Care EquipmentIndustry
Industry Ranking10/26
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE6.36%C
    • Profit Margin7.08%B
    • Gross Margin48.33%B
  • Growth ScoreC
    • Revenue YoY6.98%C
    • Net Profit YoY12.51%C
    • Total Assets YoY-6.65%D
    • Net Assets YoY9.67%B
  • Cash ScoreB
    • Cash Flow Margin1412.69%B
    • OCF YoY6.98%C
  • Operating ScoreC
    • Turnover0.54C
  • Debt ScoreB
    • Gearing Ratio34.90%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Gaush Meditech Unit Secures Global Medical-Device Quality Certification; Shares Gain 1%

    Gaush Meditech Unit Secures Global Medical-Device Quality Certification; Shares Gain 1%

    marketscreener·
    HK
    02407
    +6.19%
    marketscreener·
    HK
    02407
    +6.19%

    Gaush Meditech Unit Obtains Medical Device Registration Certificate For Product

    Gaush Meditech Ltd :UNIT OBTAINS MEDICAL DEVICE REGISTRATION CERTIFICATE FOR OPHTHALMIC ELECTROPHYSIOLOGICAL DIAGNOSTIC SYSTEMCERTIFICATE FROM GUANGDONG PROVINCIAL MEDICAL PRODUCTS ADMINISTRATION

    Reuters·
    HK
    02407
    +6.19%
    Reuters·
    HK
    02407
    +6.19%

    Gaush Meditech’s Ophthalmic Diagnostic System Gains Approval in China

    Gaush Meditech Ltd. has announced that its subsidiary, Gaush Tech, received a medical device registration certificate in China for its ophthalmic electrophysiological diagnostic system. This non-invasive system integrates Visual Evoked Potential, Electroretinography, and Electrooculography, aiding in the diagnosis and monitoring of eye diseases. The latest analyst rating for Gaush Meditech (HK:2407) is a Buy with a price target of HK$10.50. The company focuses on advanced diagnostic systems in ophthalmology and has a market cap of HK$1.33B.

    Tip Ranks·
    HK
    02407
    +6.19%
    Tip Ranks·
    HK
    02407
    +6.19%

    GAUSH MEDITECH renews exclusive agency agreement with Germany's Schwind

    GAUSH MEDITECH announced that its subsidiary Shanghai GAUSH Mingwang has renewed its exclusive agency agreement with Germany's Schwind, continuing to be responsible for sales, promotion, and related services in the Chinese market (mainland, Hong Kong, and Macau). Germany's Schwind is one of the company's most important supplier partners, and the two parties have maintained a stable partnership for over 16 years since their first collaboration in 2009

    AASTOCKS·
    HK
    02407
    +6.19%
    AASTOCKS·
    HK
    02407
    +6.19%

    GAUSH MEDITECH renews exclusive agency agreement with German company SCHWIND

    GAUSH MEDITECH has renewed its exclusive agency agreement with the German company SCHWIND, continuing to be responsible for sales, promotion, and related services in the Chinese market. Since their cooperation began in 2009, the two parties have maintained a stable partnership for over 16 years. This renewal further strengthens the strategic mutual trust between them and is of significant importance for GAUSH MEDITECH's competitive advantage in the refractive surgery equipment market in China

    Zhitong·
    HK
    02407
    +6.19%
    Zhitong·
    HK
    02407
    +6.19%
    © 2026 Longbridge｜Disclaimer